Search - tctmd.com

Displaying 1 - 19 of 19

Sort: Relevancy | Date

News Daily News

Low CV Risk With ‘Living’ Cancer Therapies, Meta-analysis Shows

L.A. McKeown

October 09, 2024

News Opinion CV Team Dispatch

August 2024 Dispatch for the CV Team

L.A. McKeown

August 01, 2024

News Daily News

CAD From Donor Hearts Warrants Follow-Up, Vigilant Risk Factor Control

Yael L. Maxwell

August 24, 2023

News Opinion CV Team Dispatch

February 2023 News Roundup

L.A. McKeown

February 15, 2023

News Daily News

Routine Coronary Tests Prior to Kidney Transplant Questioned

Yael L. Maxwell

January 05, 2023

News Daily News

COVID Drug Paxlovid Interacts With Widely Used CV Meds: Review

Todd Neale

October 12, 2022

News Opinion Editor's Corner

TCTMD’s Top 10 Most Popular Stories for March 2022

Caitlin E. Cox

April 01, 2022

News Daily News

Myocarditis After COVID Vaccination Is Rare, Resolves Quickly, Studies Confirm

L.A. McKeown

January 25, 2022

News Opinion CV Team Dispatch

February 2021 News Roundup

L.A. McKeown

February 01, 2021

News Daily News

Cardiac Transplant Patients at Higher Risk for COVID-19, Death

Caitlin E. Cox

December 09, 2020

News Opinion CV Team Dispatch

November 2020 News Roundup

L.A. McKeown

November 01, 2020

News Daily News

James T. Willerson, Revered Clinician, Editor, and Mentor, Dies at 81

L.A. McKeown

September 18, 2020

News Daily News

Don’t Overlook COVID-19’s Cardiovascular Footprint, Say NYC Physicians

Caitlin E. Cox

April 09, 2020

News Daily News

‘These Are Good Organs’: Drug Overdose Deaths Boost Transplants, With Few Downsides

Todd Neale

June 10, 2019

Presentation

Management and Outcomes of STEMIin US Renal Transplant Recipients

July 28, 2017

News Daily News

Kidney Transplant Recipients Fare About as Well as Other Patients With STEMI

Todd Neale

January 13, 2017

News Daily News

Perioperative MACCE Rate Falls but Ischemic Stroke Rises Among Noncardiac Surgery Patients

Yael L. Maxwell

January 04, 2017

News Industry News

Researchers Use Quanterix’s Simoa Technology to Detect Early Indicators of Potential Adverse Cardiovascular Outcomes

August 26, 2015

News Conference News AHA 2013

Varying Cell Therapy Techniques Demonstrate Safety, Mixed Efficacy at AHA 2013

November 17, 2013

Advertisement

Low CV Risk With ‘Living’ Cancer Therapies, Meta-analysis Shows

August 2024 Dispatch for the CV Team

CAD From Donor Hearts Warrants Follow-Up, Vigilant Risk Factor Control

February 2023 News Roundup

Routine Coronary Tests Prior to Kidney Transplant Questioned

COVID Drug Paxlovid Interacts With Widely Used CV Meds: Review

TCTMD’s Top 10 Most Popular Stories for March 2022

Myocarditis After COVID Vaccination Is Rare, Resolves Quickly, Studies Confirm

February 2021 News Roundup

Cardiac Transplant Patients at Higher Risk for COVID-19, Death

November 2020 News Roundup

James T. Willerson, Revered Clinician, Editor, and Mentor, Dies at 81

Don’t Overlook COVID-19’s Cardiovascular Footprint, Say NYC Physicians

‘These Are Good Organs’: Drug Overdose Deaths Boost Transplants, With Few Downsides

Management and Outcomes of STEMIin US Renal Transplant Recipients

Kidney Transplant Recipients Fare About as Well as Other Patients With STEMI

Perioperative MACCE Rate Falls but Ischemic Stroke Rises Among Noncardiac Surgery Patients

Researchers Use Quanterix’s Simoa Technology to Detect Early Indicators of Potential Adverse Cardiovascular Outcomes

Varying Cell Therapy Techniques Demonstrate Safety, Mixed Efficacy at AHA 2013

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content